SC Filed 2022-11-28 Event — SEC 0000919574-22-006912 →

Casdin Capital, LLC → Tenaya Therapeutics, Inc. TNYA

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

3 transactions

3 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

12 filings by this filer

11 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 7.42

24,919,430 shares short · -5.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $27K

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-05-28	Williams R Sanders	director	Award	120,000	$0.80	$96K
2026-05-28	Walsh Jeffrey T.	director	Award	120,000	$0.80	$96K
2026-05-28	Stehman-Breen Catherine	director	Award	120,000	$0.80	$96K

Other 13D/G Filings on Tenaya Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2025-05-14	SCHEDULE	COLUMN GROUP III, LP	30.30%	49,313,559	view →
2025-03-07	SCHEDULE	COLUMN GROUP III, LP	32.00%	49,313,559	view →
2025-03-07	SCHEDULE	Casdin Capital, LLC	4.30%	6,732,971	view →
2023-02-21	SC	COLUMN GROUP III, LP	—	—	view →

Other Filings by Casdin Capital, LLC

Filed	Form	Issuer	Stake	Shares
2026-06-09	SCHEDULE 13D/A	Standard BioTools Inc. LAB	23.90%	88,783,856	view →
2026-06-04	SCHEDULE 13G	BIOLIFE SOLUTIONS INC BLFS	—	—	view →
2026-05-22	SCHEDULE 13D/A	BIOLIFE SOLUTIONS INC BLFS	9.70%	4,757,165	view →
2025-08-13	SCHEDULE	BIOLIFE SOLUTIONS INC BLFS	15.00%	7,207,165	view →
2025-03-07	SCHEDULE	Tenaya Therapeutics, Inc. TNYA	4.30%	6,732,971	view →
2025-03-04	SCHEDULE	STANDARD BIOTOOLS INC. LAB	21.60%	80,864,315	view →
2024-01-09	SC	STANDARD BIOTOOLS INC. LAB	—	—	view →
2023-03-20	SC	Absci Corp ABSI	—	—	view →
2022-10-11	SC	Century Therapeutics, Inc. IPSC	—	—	view →
2020-05-18	SC	GenMark Diagnostics, Inc.	—	—	view →
2020-02-07	SC	GenMark Diagnostics, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →